BTG3 upregulation induces cell apoptosis and suppresses invasion in esophageal adenocarcinoma

被引:26
作者
Du, Yuwen [1 ]
Liu, Pingping [1 ]
Zang, Wenqiao [1 ]
Wang, Yuanyuan [1 ]
Chen, Xiaonan [1 ]
Li, Min [1 ]
Zhao, Guoqiang [1 ]
机构
[1] Zhengzhou Univ, Coll Basic Med Sci, Zhengzhou 450001, Peoples R China
关键词
Esophageal adenocarcinoma; BTG3; Proliferation; Migration; DOWN-REGULATION; LUNG-CANCER; EARLY EVENT; TUMOR; CARCINOMA; SURVIVAL; PROTEIN; TOB; PHOSPHORYLATION; CARCINOGENESIS;
D O I
10.1007/s11010-015-2363-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
B cell translocation gene 3 (BTG3) is a tumor suppressor by inhibiting cell proliferation, migration, and regulating cell cycle progression in several tumors. However, its role in esophageal adenocarcinoma (EAC) remains unknown. Here, we detected the expression of BTG3 in EAC tissues and subsequent progression. BTG3 expression was significant decreased in EAC tissues and cell lines detected by real-time RT-PCR and Western blot. Relationships of BTG3 with EAC clinicopathology were analyzed statistically. The decrease expression of BTG3 is associated with lymph node metastases. In vitro assay demonstrated that overexpression of BTG3 significantly suppressed colony formation and proliferation of EAC cells. The suppressed migration and invasion abilities found in BTG3-overexpressing EAC cells. Our findings suggested that BTG3 is suppressor in the progression of EAC.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 26 条
  • [11] Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein
    Kawakubo, Hirofumi
    Brachtel, Elena
    Hayashida, Tetsu
    Yeo, Giminna
    Kish, Joshua
    Muzikansky, Alona
    Walden, Paul D.
    Maheswaran, Shyamala
    [J]. CANCER RESEARCH, 2006, 66 (14) : 7075 - 7082
  • [12] Temporal and Spatial Evolution of Somatic Chromosomal Alterations: A Case-Cohort Study of Barrett's Esophagus
    Li, Xiaohong
    Galipeau, Patricia C.
    Paulson, Thomas G.
    Sanchez, Carissa A.
    Arnaudo, Jessica
    Liu, Karen
    Sather, Cassandra L.
    Kostadinov, Rumen L.
    Odze, Robert D.
    Kuhner, Mary K.
    Maley, Carlo C.
    Self, Steven G.
    Vaughan, Thomas L.
    Blount, Patricia L.
    Reid, Brian J.
    [J]. CANCER PREVENTION RESEARCH, 2014, 7 (01) : 114 - 127
  • [13] Loss of the candidate tumor suppressor BTG3 triggers acute cellular senescence via the ERK-JMJD3-p16INK4a signaling axis
    Lin, T-Y
    Cheng, Y-C
    Yang, H-C
    Lin, W-C
    Wang, C-C
    Lai, P-L
    Shieh, S-Y
    [J]. ONCOGENE, 2012, 31 (27) : 3287 - 3297
  • [14] The Suppressive Role and Aberrent Promoter Methylation of BTG3 in the Progression of Hepatocellular Carcinoma
    Lv, Zhenbing
    Zou, Huichun
    Peng, Kaiwen
    Wang, Jianmei
    Ding, Yi
    Li, Yuling
    Ren, Xiaoli
    Wang, Feifei
    Chang, Rui
    Liang, Li
    Ding, Yanqing
    [J]. PLOS ONE, 2013, 8 (10):
  • [15] Genistein Reverses Hypermethylation and Induces Active Histone Modifications in Tumor Suppressor Gene B-Cell Translocation Gene 3 in Prostate Cancer
    Majid, Shahana
    Dar, Altaf A.
    Shahryari, Varahram
    Hirata, Hiroshi
    Ahmad, Ardalan
    Saini, Sharanjot
    Tanaka, Yuichiro
    Dahiya, Angela V.
    Dahiya, Rajvir
    [J]. CANCER, 2010, 116 (01) : 66 - 76
  • [16] BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer
    Majid, Shahana
    Dar, Altaf A.
    Ahmad, Ardalan E.
    Hirata, Hiroshi
    Kawakami, Kazumori
    Shahryari, Varahram
    Saini, Sharanjot
    Tanaka, Yuichiro
    Dahiya, Angela V.
    Khatri, Gaurav
    Dahiya, Rajvir
    [J]. CARCINOGENESIS, 2009, 30 (04) : 662 - 670
  • [17] In search of a function for the TIS21/PC3/BTG1/TOB family
    Matsuda, S
    Rouault, JP
    Magaud, JP
    Berthet, C
    [J]. FEBS LETTERS, 2001, 497 (2-3) : 67 - 72
  • [18] Cell cycle checkpoints and their inactivation in human cancer
    Molinari, M
    [J]. CELL PROLIFERATION, 2000, 33 (05) : 261 - 274
  • [19] The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
    Ou, Yi-Hung
    Chung, Pei-Han
    Hsu, Fu-Fei
    Sun, Te-Ping
    Chang, Wen-Ying
    Shieh, Sheau-Yann
    [J]. EMBO JOURNAL, 2007, 26 (17) : 3968 - 3980
  • [20] Oesophageal carcinoma
    Pennathur, Arjun
    Gibson, Michael K.
    Jobe, Blair A.
    Luketich, James D.
    [J]. LANCET, 2013, 381 (9864) : 400 - 412